Herpes Zoster Ophthalmicus Treated With Cytarabine

Archives of Ophthalmology

Volumn 89, Issue 1, 1973, Pages 21-24

  Pierce, Lawrence E ^a   Jenkins, Ramon B ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CYTARABINE;

EYE; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; MAJOR CLINICAL STUDY; PUPIL; THERAPY; VARICELLA ZOSTER VIRUS;

ADULT; CYTARABINE; DRUG RESISTANCE; EDEMA; ERYTHEMA; HERPES ZOSTER OPHTHALMICUS; HODGKIN DISEASE; HUMAN; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGE; PREDNISONE;

EID: 0015837094     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1973.01000040023006     Document Type: Article

References (28)

1. Edgerton AE: Herpes zoster ophthalmicus. Arch Ophthalmol 34:40-62, 1945.
2. Carmody RF: Herpes zoster ophthalmicus complicated by ophthalmoplegia and exophthalmos. Arch Ophthalmol 18:707-711, 1937.
3. Blodi FC: Ophthalmic zoster in malignant disease. Am J Ophthalmol 65:686-688, 1968.
4. Allen HF: Infectious Diseases of the Conjunctiva and Cornea. St. Louis, CV Mosby Co, 1963, p 117.
5. Goldsmith MO: Herpes zoster ophthalmicus with sixth nerve palsy. Can J Ophthalmol 3:279-283, 1968.
6. Hunt JR: The paralytic complications of herpes zoster of the cephalic extremity. JAMA 53:1456-1457, 1909.
7. Lincoff HA, Wise GN, Romaine HH: Total detachment and reattachment of the retina in herpes zoster ophthalmicus. Am J Ophthalmol 41:253-256, 1956.
8. Ahmad M, Bowen SF Jr, Burke R: Optic atrophy following herpes zoster ophthalmicus in a child. Can J Ophthalmol 4:387-389, 1969.
9. Wallk S, McNeese J: Herpes zoster with ocular destruction. Arch Dermatol 101:238-239, 1970.
10. Buthala DA: Cell culture studies on antiviral agents: I. Action of cytosine arabinoside and some comparisons with 5-iodo-2-deoxyuridine. Proc Soc Exp Biol Med 115:69-77, 1964.
11. McKelvey ER, Kwaan HC: Cytosine arabinoside therapy for disseminated herpes zoster in a patient with IgG pyroglobulinemia. Blood 34:706-711, 1969.
12. Chow AW, Foerster J, Hryniuk W: Cytosine arabinoside therapy for herpesvirus infections. Antimicrob Agents Chemother 1970, pp 214-217.
13. Hall T, et al: Treatment of varicella-zoster with cytosine arabinoside. Clin Res 17:470, 1969.
14. Talley RW, et al: Clinical pharmacology and human antitumor activity of cytosine arabinoside. Cancer 20:809-816, 1967.
15. Neilan BA, Schechter GP: Disseminated herpes zoster: Treatment with cytosine arabinoside. Med Ann DC 40:573-576, 1971.
16. Blank H, Eaglstein WH, Goldfaden GL: Zoster, a recrudescence of V-Z virus infection. Postgrad Med J 46:653-658, 1970.
17. Merselis JG, Kaye D, Hook EW: Disseminated herpes zoster. Arch Intern Med 113:679-686, 1964.
18. Burgoon CF, Burgoon JS, Baldridge GD: The natural history of herpes zoster. JAMA 164:265-269, 1957.
19. Scheie HG: Herpes zoster ophthalmicus. Trans Ophthalmol Soc UK 90:899-930, 1970.
20. Freiwald MJ: Herpes zoster ophthalmicus. Med Times 96:43-49, 1968.
21. Scheie HG, Alper MC: Treatment of herpes zoster ophthalmicus with cortisone or corticotropin. Arch Ophthalmol 53:38-44, 1955.
22. Rifkind D: The activation of varicellazoster virus infection by immunosuppressive therapy. J Lab Clin Med 68:463-474, 1966.
23. Sokal JE, Firat D: Varicella-zoster infection in Hodgkin's disease. Am J Med 39:452-463, 1965.
24. Stevens DA, Merigan TC: Host factors in dissemination of herpes zoster. J Clin Invest 50:88a, 1971.
25. Waltuch G, Sachs F: Herpes zoster in a patient with Hodgkin's disease. Arch Intern Med 121:458-462, 1968.
26. Underwood GE, Wisner CA, Weed SD: Cytosine arabinoside (CA) and other nucleosides in herpes virus infections. Arch Ophthalmol 72:505-512, 1964.
27. Chu MY, Fisher GA: A proposed mechanism of action of 1-B-D-arabino-furanosyl-cytosine as an inhibitor of the growth of leukemic cells. Biochem Pharmacol 11:423-430, 1962.
28. Mann JR: Cytosine arabinoside and herpes zoster. Lancet 2:166, 1971.